Silke Schelenz

66 papers receiving 2.8k citations

Hit Papers

First hospital outbreak of the globally emerging Candida ...201620262019202220162017100200300400500

Peers

Silke Schelenz
Comparison fields: 5 of 120
  • Infectious Diseases 2.1k
  • Epidemiology 1.6k
  • Molecular Biology 312
  • Pulmonary and Respiratory Medicine 308
  • Applied Microbiology and Biotechnology 195
Replace V. Krčméry with:
V. Krčméry Slovakia
Joveria Farooqi Pakistan
Kimberly E. Hanson United States
Kauser Jabeen Pakistan
F Sánchez Spain
Hiroshi Kakeya Japan
A. Houston United States
Christine C. Chiou United States
Eiman Mokaddas Kuwait
Dionysios Neofytos Switzerland
Silke Schelenz relative to V. Krčméry Slovakia V. Krčméry's profile →
Citations per field
00.5×7.5×
V. Krčméry · 1×
Citations per year

Countries citing papers authored by Silke Schelenz

Since Specialization
Citations

This map shows the geographic impact of Silke Schelenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Schelenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Schelenz more than expected).

Fields of papers citing papers by Silke Schelenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Schelenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Schelenz. The network helps show where Silke Schelenz may publish in the future.

Co-authorship network of co-authors of Silke Schelenz

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Schelenz. A scholar is included among the top collaborators of Silke Schelenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Schelenz. Silke Schelenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 3
4 3
5 6
6 1
7 42
8 78
9 45
10 14
11 37
12 9
13 41
14 130
15 17
16 39
17 74
18 13
19 76
20 45

About Silke Schelenz

Silke Schelenz is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Microbiology, having authored 75 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (44 papers), Fungal Infections and Studies (26 papers) and Cystic Fibrosis Research Advances (9 papers). The work is most often cited by research in Infectious Diseases (2.1k citations), Applied Microbiology and Biotechnology (195 citations) and Epidemiology (1.6k citations). Silke Schelenz has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Darius Armstrong‐James, Alireza Abdolrasouli, Elizabeth M. Johnson, Colin Brown, Andrew M. Borman, Jacques F. Meis, Anuradha Chowdhary, Matthew C. Fisher, Johanna Rhodes and Rohini Manuel. Their work appears in journals such as Clinical Microbiology Reviews, Kidney International and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026